Background: Rett syndrome (RTT) is an X linked neuro-developmental disorder affecting mostly girls. Mutations in the coding region of MECP2 are found in 80% of classic RTT patients. Until recently, the region encoding MECP2 was believed to comprise exons 2, 3, and 4 with the ATG start site located at the end of exon 2 (MeCP2_e2).
Methods: Recent reports of another mRNA transcript transcribed from exon 1 (MeCP2_e1) prompted us to screen exon 1 among RNA samples from 20 females with classic or atypical RTT.
Results: A previously reported 11 base pair deletion in exon 1 was detected in one subject with a milder phenotype. Although RNA expression for both protein isoforms was detected from the mutant allele, evaluation of MeCP2 protein in uncultured patient lymphocytes by immunocytochemistry revealed that MeCP2 protein production was restricted to only 74–76% of lymphocytes. X chromosome inactivation studies of genomic DNA revealed similar XCI ratios at the HUMARA locus (73:27 with HpaII and 74:26 with McrBC). We have demonstrated that translation but not transcription of the MeCP2_e2 isoform is ablated by the 11 nucleotide deletion, 103 nucleotides upstream of the e2 translation start site.
Conclusions: These findings reveal that nucleotides within the deleted sequence in the 5′-UTR of the MeCP2_e2 transcript, while not required for transcription, are essential for translation.
- Rett syndrome
- RNA secondary structure
Statistics from Altmetric.com
Published Online First 12 September 2005
The authors would like to acknowledge the Raine Foundation and Rett Syndrome Australian Research Fund for funding of this project as well as the National Institute of Child Health and Human Development for its current funding of the Australian Rett Syndrome Database under NIH grant number 1 R01 HD43100-01A1 PI. InterRett is funded by the International Rett Syndrome Association. DR is supported by a grant from the University of Western Australia, HL is funded by NHMRC program grant 353514, and JC is funded by NHMRC project grants 185202 and 346603.
Competing interests: none declared
Patient details are published with consent
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.